Foundation Medicine Launches FoundationOne®Tracker ctDNA Monitoring Assay for Research Use in Partnership with Natera
- Tuesday, June 8, 2021, 6:31
- Environment
- Add a comment
CAMBRIDGE, Mass. and AUSTIN, Texas, June 8, 2021 /PRNewswire/ — Foundation Medicine, Inc. and Natera, Inc. (NASDAQ: NTRA), today announced the launch of the research use version of FoundationOne®Tracker, Foundation Medicine’s personalized circulating tumor DNA (ctDNA) monitoring assay….
About the Author
adminasapcorp has written 41546 stories on this site.